Results 91 to 100 of about 12,647 (196)

ATYPICAL HEMOLYTIC UREMIC SYNDROME DIAGNOSIS AND TREATMENT

Hematology, Transfusion and Cell Therapy
Atypical hemolytic uremic syndrome (aHUS), more commonly known as complement-related HUS is a kind of thrombotic microangiopathy (TMA) characterized by inherited pathogenic variants in complement genes or acquired autoantibodies against complement ...
Atakan Turgutkaya
doaj   +1 more source

Clinical practice guidelines for the management of atypical haemolytic uraemic syndrome in the United Kingdom [PDF]

, 2010
,, Goodship, Tim H J, Machin, Sam, Taylor, C Mark, Wigmore, Stephen J   +4 more
core   +1 more source

Acute kidney injury in pregnancy: a clinical challenge [PDF]

, 2012
The incidence of acute kidney injury in pregnancy declined significantly over the second half of the 20th century; however, it is still associated with major maternal and perinatal morbidity and mortality.
Borges, A, Campos, M, Figueiredo, N, Freitas, L, Machado, S, Moura, P, Pais, MS   +6 more
core  

Haemolytic uraemic syndrome caused by factor H mutation: is single kidney transplantation under intensive plasmatherapy an option? [PDF]

, 2017
Complement factor H (CFH) mutation is one of the causes of atypical haemolytic uraemic syndrome (aHUS). Patients with CFH mutation-associated aHUS progress often to end-stage renal disease despite plasma exchange therapy.
Dickenmann, Michael, Frémeaux-Bacchi, Véronique, Hirt-Minkowski, Patricia, Mayr, Michael, Schaub, Stefan, Schifferli, Jürg A., Steiger, Jürg   +6 more
core  

Atypical Hemolytic Uremic Syndrome [PDF]

, 2020
openaire   +3 more sources

Neonatal Hemolytic Uremic Syndrome After Mother-to-Child Transmission of a Low-Pathogenic stx2b Harboring Shiga Toxin-Producing Escherichia coli [PDF]

, 2017
This case describes evidence for a Shiga toxin-producing Escherichia coli (STEC) O146:H28 infection leading to hemolytic uremic syndrome in a neonate. STEC O146:H28 was linked hitherto with asymptomatic carriage in humans. Based on strain characteristics
Bucher, Barbara S., Hächler, Herbert, Kottanattu, Lisa, Simonetti, Giacomo D., Steinmann, Markus, Stephan, Roger, Stritt, Andrea, Tschumi, Sibylle, von Steiger, Niklaus   +8 more
core  

Overcoming technical challenges when treating atypical hemolytic uremic syndrome with therapeutic plasma exchange

International Journal of Nephrology and Renovascular Disease, 2013
Edward Zimbudzi Department of Nephrology, Monash Health, Monash Medical Centre, Victoria, Australia Abstract: Atypical hemolytic uremic syndrome (aHUS) is a very rare, life-threatening, progressive disease that frequently has a genetic component and in ...
Zimbudzi E
doaj  

Atypical hemolytic-uremic syndrome (aHUS)

, 2019
Abstract Atypical hemolytic-uremic syndrome (aHUS) is a diagnosis of exclusion which should be proposed in cases where there is microangiopathic hemolytic anemia, thrombocytopenia and acute kidney injury. It is associated with mutations which cause dysregulation of the complement system and implies an adverse prognosis and a high risk of progression to
Domínguez-Ramírez, Gustavo Adolfo, Blanco-Pertuz, Paola María, Herrera-Rueda, Guillermo Andrés   +2 more
openaire   +1 more source

Optimal management of atypical hemolytic uremic disease: challenges and solutions

International Journal of Nephrology and Renovascular Disease, 2019
Rupesh Raina1,2,*, Manpreet K Grewal2,*, Yeshwanter Radhakrishnan3, Vineeth Tatineni4, Meredith DeCoy5, Linda LG Burke5, Arvind Bagga6 1Department of Nephrology, Akron Children’s Hospital, Akron, OH, USA; 2Akron Nephrology Associates, Cleveland ...
Raina R, Grewal MK, Radhakrishnan Y, Tatineni V, DeCoy M, Burke LLG, Bagga A   +6 more
doaj  

Functional analyses indicate a pathogenic role of factor H autoantibodies in atypical haemolytic uraemic syndrome [PDF]

, 2010
Hoyer, P. F., Józsi, Mihály, Liu, W. S., Mache, C. J., Strobel, S., Sulyok, Endre   +5 more
core   +1 more source